Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Akston, Brii, Eli Lilly, Humanigen, Immutep, Incyte, Jacobio, Kiniksa, Lumosa, Novavax, Pharmaxis, RDIF, Stemedica Cell Technologies, Takeda, Telix, Vanda.